LC
LLY icon

Lavaca Capital’s Eli Lilly LLY Stock Holding History

Lavaca Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,800
Closed -$897K – 170
2021
Q1 		$897K Buy
+4,800
New +$939K 0.08% 68

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lavaca Capital's LLY Position: Q1 2026 in Review

Lavaca Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 386 shares worth $355K. The position accounts for 0.06% of the portfolio, ranked #81.

Lavaca Capital first reported a position in LLY in Q4 2018 and has held it in 25 quarters since. The position peaked at $3.71M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lavaca Capital held 386 shares of Eli Lilly worth $355K as of Q1 2026.
  • Lavaca Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.06% of Lavaca Capital's portfolio in Q1 2026, its #81 holding.
  • Lavaca Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 25 quarters since.
  • Lavaca Capital's Eli Lilly position peaked at $3.71M in Q4 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.